7 years ago

Abingdon Health Secures £1.5 Million in Funding for Expansion

  • Abingdon Health, a York, UK-based rapid diagnostics company, secured £1.5 million in funding from NPIF - Mercia Equity Finance, managed by Mercia Fund Managers

  • The funds will be used to fulfill new contract wins and invest in new equipment and processes at its headquarters

  • Abingdon Health specializes in 'point of care' tests, providing single-use devices for on-site testing in various sectors

  • The company develops and manufactures tests for clients worldwide, with over 50% of its output going to export markets.

      • ProblemHealthcare

      "Diagnosing diseases in humans, animals, and plants is slow and inefficient, with traditional laboratory tests requiring significant time and resources. This slows down treatment and can impact overall health outcomes."

      Solution

      "Abingdon Health develops rapid diagnostic tests that are simple to use and can be performed at the point of care, meaning results are available quickly and can be interpreted by eye or using a smartphone app. This speeds up diagnosis and monitoring and can be used in a variety of settings, including healthcare facilities, veterinary practices, and food and agriculture settings."

      Covered on